Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shire Regenerative Medicine Inc.

Division of Shire PLC
www.shire.com

Latest From MolMed SPA

EMA, FDA Talk Real World Evidence, Mutual Recognition, Generic Drugs

US FDA and European Medicines Agency may expand sharing beyond manufacturing inspections to clinical trials and generic drug applications.

FDA Drug Approval Standards

Pulled From EU Assessment Process: Orphan Drugs For Kidney Disease, Mesothelioma

Two orphan medicines have been withdrawn from the evaluation process at the European Medicines Agency, one of them for recurrent nephrotic syndrome, the other for mesothelioma. Three products are undergoing a re-evaluation after an initial negative opinion from the CHMP.

Drug Review Europe

Finance Watch: Two More US Biopharma IPOs And Two New European VC Funds

Two biopharma IPOs in the US continue streak of (mostly) positive returns; two new European VC funds launch as Irish antibiotic developer raises $65m; and Halozyme, Ziopharm price offerings.

Business Strategies Commercial

AstraZeneca, Eli Lilly and Cancer Dominate 2016 EU New Drug Approvals

2016 saw 30 new active substances approved in the EU, in a total of 29 different products, of which 10 were for cancer indications. Two companies shared the honors for productivity: AstraZeneca and Lilly each saw three new active substances approved by the European Commission during the year.

Europe Approvals
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Dermatology
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Advanced BioHealing Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Shire PLC
  • Senior Management
  • Jeff Jonas, MD, Pres.
  • Contact Info
  • Shire Regenerative Medicine Inc.
    11095 Torreyana Rd.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register